Beda Pharmaceutical (300558.SZ) released its financial performance for the first half of the year, with a net profit attributable to the parent company of 140 million yuan, a decrease of 37.53%.

Wisdom Financial News APP News, Beida Pharmaceutical (300558.SZ) released its 2025 semi-annual report. The company's operating income was 1.731 billion yuan, a year-on-year increase of 15.37%. Net profit attributable to the company's shareholders was 140 million yuan, a year-on-year decrease of 37.53%. Net profit attributable to the company's shareholders excluding non-recurring gains and losses was 191 million yuan, a year-on-year decrease of 11.97%. Basic earnings per share were 0.33 yuan.